NeuroPace Inc. (NPCE)
NASDAQ: NPCE
· Real-Time Price · USD
8.44
-0.12 (-1.40%)
At close: Aug 18, 2025, 3:59 PM
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Non-Us Revenue | 200K | 100K |
| Non-Us Revenue Growth | +100.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 18.11M | 15.05M | 13.79M | 13.91M | 14.3M | 15.1M | 13.22M | 13.39M | 14.48M | 13.43M | 13.57M | 12.55M | 12.77M | 12.44M | 11.75M | 9.42M | 9.53M | 8.27M | 7.28M | 7.05M | 5.62M | 7.68M |
| Selling, General, and Administrative Revenue Growth | +20.35% | +9.12% | -0.85% | -2.73% | -5.33% | +14.26% | -1.26% | -7.56% | +7.86% | -1.07% | +8.13% | -1.71% | +2.63% | +5.94% | +24.68% | -1.11% | +15.24% | +13.54% | +3.28% | +25.56% | -26.91% | n/a |
| Research and Development Revenue | 6.84M | 7.44M | 6.05M | 5.75M | 6.07M | 5.78M | 5.38M | 4.79M | 5.34M | 5.26M | 5.09M | 5.61M | 5.67M | 5.58M | 5.34M | 4.33M | 4.44M | 4.1M | 3.92M | 3.69M | 3.25M | 4.83M |
| Research and Development Revenue Growth | -8.00% | +22.98% | +5.14% | -5.13% | +4.86% | +7.57% | +12.14% | -10.26% | +1.52% | +3.42% | -9.30% | -1.02% | +1.65% | +4.34% | +23.47% | -2.43% | +8.22% | +4.62% | +6.18% | +13.50% | -32.71% | n/a |
| Sales and Marketing Revenue | 12.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |